Market Expertise

Niche market understanding means that we develop ontologies and analytical tools tailored to the needs of fast-moving, emerging therapeutic modalities.

Unmatched Data Quality

Timely, accurate, comprehensive data with a zero-tolerance approach to errors and inaccuracies – ensuring you have confidence in your research.

Customer Centric

Close client relationships enable continued agile product development and evolution to meet your emerging needs.

Our Dataset Solutions

ADC
Bispecific
Cancer Vaccine
Cell Therapy
Checkpoint
Cytokine
DDR
Gene Therapy
Immune Tolerance
Microbiome
Oncolytic Viruses
RNA
TPD
Beacon ADC Logo

 

Covering all Antibody Drug Conjugates (ADCs), Small Molecule Drug Conjugates (SMDCs), Protein Drug Conjugates (PDCs), Immunotoxins and more

Find out more

Beacon Bispecific Logo

 

Covering all Bi- and Multi-Specific Antibodies, Antibody Fragments, Augmented Antibodies and more

Find out more

Cancer Vaccine Logo 2021

 

Beacon Cancer Vaccine provides the solution you need to master the prophylactic and therapeutic cancer vaccines field.

Find out more

 

Beacon Cell Therapy covers genetically and non-genetically engineered allogeneic and autologous cell-based therapies across all disease indications.

Find out more

Beacon Checkpoint Logo

 

Covering all Immune Checkpoint Combination Trials and Immune Checkpoint Modulators in development across 27 different checkpoint targets

Find out more

 

Covering all cytokines and drugs that target a cytokine or its immediate receptor belonging to the Interleukins, Interferons, Colony-stimulating factors, Transforming growth factor β, Tumour necrosis factor and Chemokines families.

Find out more

Beacon DDR Logo

 

Beacon DDR steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the DDR field.

Find out more

Beacon Gene Therapy Logo

 

From gene-editing technologies, novel delivery systems, and a variety of genetic materials being used- Beacon Gene Therapy steps into the field to give drug developers a precise and detailed view of how the gene therapy landscape looks.

Find out more

 

Covering all therapeutics aimed at treating immune-mediated diseases – Beacon Immune Tolerance provides drug developers with detailed views of the expanding immune tolerance landscape.

Find out more

 

Covering all pharmaceutical grade microbiome-based therapeutics across all disease indications – Beacon Microbiome provides drug developers with detailed views of the expanding microbiome landscape.

Find out more

Beacon Oncolytic Viruses Logo

 

From capturing viral family and strains to understanding any genetic modifications – Beacon Oncolytic Viruses steps into the field to give drug developers the precise detailed view and broader picture of what is truly happening in the Oncolytic Virus field.

Find out more

 

Covering Oligonucleotide-based, mRNA-Based, Ribozyme, and gRNA-Mediated Gene Editing therapies, as well as RNA-Targeted Small Molecules – Beacon RNA covers all disease indications and many modalities to provide a detailed landscape of the RNA space.

Find out more

Beacon TPD Logo

 

Beacon TPD provides the solution you need to master the targeted protein degradation field.

Find out more

What our customers say

“Beacon is helpful when I need data on the fly. I find it valuable to be able to go through the platform quickly and see the up to date status of ADCs and targets”

Chief Development Officer
BioPharma Consulting

"Beacon is a great database that people should pay attention to. It's much better than many of the more generic databases that try to capture all data about everything."

Director
Small Biotech

Download our Brochure

Discover how Beacon can improve your capabilities in developing complex therapeutics by downloading our brochure and exploring the Drugs & Trials database solutions.

Download our Brochure

Book a Demonstration

Ready to unlock the full potential of Beacon? Schedule a personalized demo now and discover how our innovative solution can transform your approach to therapeutic development.

Book a Demonstration

Our Latest Content

H1 2024 Oncolytic Viruses Landscape Review

Find out more

H1 2024 Cytokine Landscape Review

Find out more

H1 2024 Cancer Vaccine Landscape Review

Find out more

H1 2024 Microbiome Landscape Review

Find out more

The 2024 H1 TPD Landscape Review

Find out more

H1 2024 Immune Tolerance Landscape Review

Find out more

H1 2024 Bispecific Landscape Review

Find out more

H1 2024 RNA Landscape Review

Find out more

H1 2024 Gene Therapy Landscape Review

Find out more
logo